Click to search for your profile
Click to search for condition or expert
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Clinical Trials for
Adenoid Cystic Carcinoma
Overview
Find a Doctor
Latest Advances
Clinical Trials
Active Clinical Trials
Search for trials
Clinical Trial
Status:
Recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
30
Start Date:
September 1, 2020
Study on the Treatment of Refractory and Locally Advanced Head and Neck Malignant Tumor With Anlotinib Hydrochloride Capsules Combined With Chemoradiotherapy
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
64
Start Date:
June 2, 2020
A Phase II Study of Lenvatinib Plus Pembrolizumab in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
Search for trials
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
30
Start Date:
June 2020
A Prospective, Open-label, Randomized Controlled Clinical Study to Evaluate the Efficacy and Safety of All-trans Retinoic Acid (ATRA) in the Treatment of Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
10
Start Date:
May 26, 2020
Lutetium-177-PSMA Radioligand Therapy for Advanced Salivary Gland Cancer, a Phase II Pilot Study.
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
72
Start Date:
March 4, 2020
A Phase 2 Open-Label, Multicenter, Study to Evaluate the Efficacy and Safety of Rivoceranib in Subjects With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) of All Anatomic Sites of Origin
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Radiation
Participants:
314
Start Date:
December 15, 2019
Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
30
Start Date:
July 22, 2019
A Phase 2 Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma (ACC)
Clinical Trial
Status:
Recruiting
Intervention Type:
Radiation
Participants:
40
Start Date:
July 16, 2019
Sperimentazione Clinica Del Sistema INSIDE - Innovative SolutIons for DosimEtry in Hadrontherapy - Per il Monitoraggio Del Trattamento in Adroterapia
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
87
Start Date:
December 14, 2018
A Phase 2, Open-Label, Multi-center Study of AL101 in Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
25
Start Date:
September 5, 2018
The Efficacy of Cabozantinib in Advanced SAlivary Gland Cancer Patients, a Phase II Clinical Trial
Clinical Trial
Status:
Recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
54
Start Date:
June 8, 2018
An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects With Solid Tumors or Lymphoma
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
22
Start Date:
June 6, 2018
Chidamide Combined With Cisplatin in Recurrent or Metastatic Head and Neck Adenoid Cystic Carcinoma: A Prospective, Open-label, Phase II Study of a Single Center